We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1012 for:    Recruiting, Not yet recruiting Studies | adolescent OR behavior* OR psych*
Previous Study | Return to List | Next Study

Interventions for Adolescent Obesity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03004378
Recruitment Status : Not yet recruiting
First Posted : December 28, 2016
Last Update Posted : January 5, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
This study will be the first to evaluate whether the short- and long-term use of activity tracking devices improve short- and long-term weight loss in adolescents. The investigators will be the first to establish whether weight loss translates into a change in obesity-related biomarkers associated with adolescent obesity. In addition, the investigators will be the first to report outcomes after the implementation of activity tracking devices in conjunction with an intense adolescent weight loss program.

Condition or disease Intervention/treatment
Adolescent Obesity Device: Fitbit

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Role of Activity Tracking on Weight Loss in Obese Adolescents
Study Start Date : January 2017
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : September 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Weight Control
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
No Intervention: Control
Intervention
Receive Fitbit
Device: Fitbit


Outcome Measures

Primary Outcome Measures :
  1. Weight loss in obese adolescents after Fitbit intervention [ Time Frame: 3 years ]
  2. Change in nutrition habits after Fitbit intervention, through survey administration [ Time Frame: 3 years ]
  3. Change in exercise habits after Fitbit intervention, through survey administration [ Time Frame: 3 years ]

Secondary Outcome Measures :
  1. Measure hemoglobin A1C changes in obese adolescents [ Time Frame: 3 years ]
  2. Measure cholesterol changes in obese adolescents [ Time Frame: 3 years ]
  3. Measure tryglyceride changes in obese adolescents [ Time Frame: 3 years ]
  4. Measure high density lipoprotein cholesterol changes in obese adolescents [ Time Frame: 3 years ]
  5. Measure low density lipoprotein cholesterol changes in obese adolescents [ Time Frame: 3 years ]
  6. Measure gamma-glutamyl transferase level changes in obese adolescents [ Time Frame: 3 years ]
  7. Measure C-reactive protein changes in obese adolescents [ Time Frame: 3 years ]
  8. Measure insulin level changes in obese adolescents [ Time Frame: 3 years ]
  9. Measure leptin level changes in obese adolescents [ Time Frame: 3 years ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Subject has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures.
  2. At least 12 and younger than 18 years of age at the time of consent.
  3. BMI ≥ 95th percentile for age and sex group or BMI ≥ 35 kg/m2

Exclusion Criteria:

  1. Any medical condition that, in the opinion of the investigator, would place the subject at increased risk for participation.
  2. Use of an investigational agent in the 30 days prior to signing informed consent
  3. History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the subject to comply with the study procedures or follow the investigators instructions.
  4. Females who are pregnant or lactating
  5. Subjects taking medications that can potentially cause weight gain
  6. Subjects unable to participate in the comprehensive weight loss program due to pre-existing conditions (paralysis, heart failure, severe autism or mental retardation, psychosis, etc.)
  7. Prisoners
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03004378


Contacts
Contact: Kanika Bowen-Jallow, MD 409-772-5666 kabowen@utmb.edu
Contact: Lindsey Berry, MSN, PNP 409-772-5666 ext 1028 lmberry@utmb.edu

Sponsors and Collaborators
The University of Texas Medical Branch, Galveston
More Information

Publications:
Responsible Party: The University of Texas Medical Branch, Galveston
ClinicalTrials.gov Identifier: NCT03004378     History of Changes
Other Study ID Numbers: 160241
First Posted: December 28, 2016    Key Record Dates
Last Update Posted: January 5, 2017
Last Verified: December 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by The University of Texas Medical Branch, Galveston:
obesity
adolescent
tracking device
fitbit

Additional relevant MeSH terms:
Obesity
Pediatric Obesity
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms